Michael S Abrams is CHIEF FINANCIAL OFFICER of Arch Therapeutics, Inc.. Currently has a direct ownership of 10,292 shares of ARTH, which is worth approximately $3,602. The most recent transaction as insider was on Aug 31, 2023, when has been sold 10,292 shares (Common Stock) at a price of $0.28 per share, resulting in proceeds of $2,881. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.3K
0% 3M change
0% 12M change
Total Value Held $3,602

MICHAEL S ABRAMS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 31 2023
BUY
Open market or private purchase
$2,881 $0.28 p/Share
10,292 Added 50.0%
10,292 Common Stock
Jul 06 2022
BUY
Grant, award, or other acquisition
-
108,652 Added 50.0%
108,652 Common Stock
MSA

Michael S Abrams

CHIEF FINANCIAL OFFICER
Framingham, MA

Track Institutional and Insider Activities on ARTH

Follow Arch Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARTH shares.

Notify only if

Insider Trading

Get notified when an Arch Therapeutics, Inc. insider buys or sells ARTH shares.

Notify only if

News

Receive news related to Arch Therapeutics, Inc.

Track Activities on ARTH